RVRene Voboril

Rene Voboril

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Rene Voboril has a total of 66 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Is high age a contraindication to pulmonary resection?

    by Pavel Horák, Mariya Kengbaeva, Jan Doležal, Natália Harciníková, Jan Fanta, René Vobořil

    Introduction: As the population ages, there are increasing numbers of elderly patients diagnosed with operable primary pulmonary malignancy or other lesions requiring pulmonary resection. The objective of the study was to evaluate post-operative outcomes in the elderly group and compare them with younger patients undergoing the same surgery. Methods: Retrospectively, we evaluated our own set of 424 patients undergoing anatomical pulmonary resection for primary lung cancers and other resectable lesions in 2011−2020. 328 patients underwent open procedures, and VATS lobectomy was performed 96 times. We evaluated the set of patients in terms of 30-day morbidity and mortality using Clavien-Dindo classification modified for pulmonary resections. We compared the patient subgroups by age (under 55, 55−64 years old, 65−74 years and over 75 years). Results: A non-biometric Kruskal-Wallis test was used to compare the groups. We have not shown a statistically significant difference in the number of complications (p=0.220). Conclusion: Standard surgical treatment for non-small cell lung carcinoma, lobectomy with systematic mediastinal lymphadenectomy, is safe also for a well-indicated group of seniors. With careful preoperative assessments and consideration of the extent of resection, we can expect a comparable rate of complications in the elderly compared to younger patients. Sublobar resection or radiotherapy should be considered in case of patients at risk. For seniors over 70 years of age, comparable outcomes of oncological treatment can be reached, taking into account their shorter life expectancy.


  • Open Access

    The changes of tumour vascular endothelial growth factor expression after neoadjuvant chemoradiation in patients with rectal adenocarcinoma

    by David Buka, Josef Dvorak, Veronika Sitorova, Igor Sirak, Rene Voboril, Bohuslav Melichar, Igor Richter

    Aim of the study : The aim was to examine the effects of neoadjuvant chemoradiotherapy on VEGF expression in patients with locally advanced rectal cancer. Materials and methods : A total of 53 patients with locally advanced rectal cancer were retrospectively studied. Neoadjuvant treatment...


  • NF-κB/p65 expression before and after treatment in rectal cancer patients undergoing neoadjuvant (chemo)radiotherapy and surgery: prognostic marker for disease progression and survival

    by R. Voboril, V. Rychterova, J. Voborilova, M. Kubecova, J. Fanta, J. Dvorak

    NF-κB/p65 expression before and after treatment in rectal cancer patients undergoing neoadjuvant (chemo)radiotherapy and surgery: prognostic marker for disease progression and survival


  • Open Access

    Transient and Non-Transient Intussusceptions of the Large Bowel in Adults: Two Case Reports

    by René VobořIl, Jan Fanta, Petr Bačkovský, Daniel Ehrenberger, Jana VobořIlová

    Background: Intussusception of the large bowel in adults is a very rare pathological condition. However, it has its clinical importance because intussusception is very often associated with an intraluminal lesion. Case report: We report two cases of the large bowel intussusception, ileocolic and colorectal. Both intussusceptions were associated with a malignant tumor. However, the clinical presentation was different. One of the intussusceptions was of non-transient character, while the second one resolved spontaneously before operation. Both patients underwent surgery and malignant tumors were found and removed. Results: The purpose of the article is to draw attention to intussusception and emphasize that intussusception, either transient or non-transient, should be further examined. Conclusions: The intussusception may be the first and the only signal of the existence of a malignant tumor, very often colorectal carcinoma.


  • Dissociated invasively growing cancer cells with NF-kappaB/p65 positivity after radiotherapy: a new marker for worse clinical outcome in rectal cancer? Preliminary data

    by Rene Voboril, Jana Voborilova, Vlasta Rychterova, Tomas Jirasek, Josef Dvorak

    Objectives Nuclear factor-kappaB (NF-κB), especially p65 subunit, seems to be associated with origin and progression of cancer. The aim of the study was to determine expression of NF-κB/p65 in rectal cancer patients before and after radiotherapy as well as to assess the relationship between NF-κB/p65 expression, other tumor characteristics, and disease progression. Further aim was to evaluate whether expression of NF-κB/p65 in tumor tissue may serve as a predictive marker of patient outcome. Patients and methods Twenty-five patients with rectal cancer undergoing pre-operative radiotherapy were included in the study. Unirradiated rectal cancer specimens were obtained from diagnostic colonoscopy. Irradiated rectal cancer specimens were obtained from surgically removed part of the rectum with the tumor. NF-κB/p65 expression was determined by immunohistochemistry. Results Cytoplasmic positivity in cancer cells and nuclear positivity in lymphocytes were detected. In post-radiotherapy specimens single tumor cells or small clones of them deeply infiltrating the wall of the rectum, that were characterized by high NF-κB/p65 expression, were found. Patients with presence of these cells in post-radiotherapy specimens have worse clinical outcome in terms of overall survival and disease-free interval. Conclusion While the NF-κB/p65 positive staining of the epithelial cells did not have any clinical implications in this study, it may be of clinical significance in the future. Residual invasively growing cancer cells with high NF-κB/p65 positivity found in specimens after radiotherapy and surgery may be used to find what patients have a worse outcome. Thus, patients being at risk of cancer progression and requiring more aggressive anti-cancer therapy may be identified.


    • 1 May 2007
      • Vol. 86  (5) , 268-72

    [NF-kappaB, colorectal carcinoma and radiotherapy: results of a clinical and experimental study].

    by R Voboril, J Weberová-Voborilová, V Rychterová, M Ambrus, L Horák, J Fanta

    Resistance to radiotherapy often seen in rectal cancer patients requires intensive study of mechanisms taking part in this process. It seems that nuclear factor-kappaB (NF-kappaB), especially its subunit p65, could play an important role in radioresistance. The aims of this study were: 1. to assess expression of p65 in rectal cancer patients and to evaluate its possible predictive role; 2. to determine in in vitro experiments possibilities of p65 modulation and to evaluate, whether this modulation can result in enhacement of efficiency of radiation therapy. We found that the level of NF-kappaB expression may serve as a predictive marker of overall survival. Further we found that inhibition of NF-kappaB activity caused by radiation improves impact of radiation therapy.

    • 1 January 2007
      • Vol. 54  (6) , 495-502

    Sensitization of colorectal cancer cells to irradiation by IL-4 and IL-10 is associated with inhibition of NF-kappaB.

    by R Voboril, J Weberova-Voborilova

    The efficiency of radiotherapy for rectal cancer treatment is limited because of radioresistance. Transcription factor nuclear factor-kappaB (NF-kappaB), which has antiapoptotic properties, may play an important role in this process. Recent studies indicate that behavior of the tumor is done not only by oncogenic events in tumor cells but also by microenvironment surrounding the tumor. Therefore we tested anti-inflammatory cytokines IL-4 and IL-10 occurring in tumor stroma whether they can modulate response of colorectal cancer cells to irradiation and whether this potential effect is associated with NF- kappaB. SW620 colorectal cancer cells were used for all experiments. Cell growth and clonogenicity were determined by cell proliferation assay and clonogenic assay, respectively. Activation of NF-kappaB was assessed by ELISA-based transcription factor assay and luciferase reporter assay. Apoptosis was determined by measuring caspase 3 activity. Irradiation (2-8 Gy) inhibited growth and clonogenicity of SW620 cells, induced apoptosis, and activated NF-kappaB, predominantly its subunits p50, p65, and RelB. IL-4 or IL-10 (1, 10, 100 ng/ml) neither inhibited growth and clonogenicity nor activated NF-kappaB, but they sensitized cells to irradiation in a dose dependent manner. Radiosensitization by IL-4 or IL-10 was associated with inhibition of NF-kappaB, predominantly its subunits p50 and p65 and increased apoptosis. In conclusion, modulation of the intestinal microenvironment, high local concentration of anti-inflammatory cytokines such as IL-4 and IL-10 may help to overcome resistance of colorectal tumors to radiotherapy. In this process NF-kappaB may be employed.


    • 8 November 2006
      • Vol. 53  (71) , 702-4

    Intraluminal high dose rate brachytherapy of tumorous esophageal stenoses.

    by Josef Dvorak, Jiri Petera, Karel Kabelac, Bohuslav Melichar, Rene Voboril, Stanislav Filip, Milan Vosmik, Petr Hulek

    The prognosis of inoperable carcinomas of esophagus is poor, and therapeutic efforts are generally limited to palliation. The aim of this study was to retrospectively evaluate the effectiveness of intraluminal high dose rate brachytherapy in the palliative treatment of tumorous esophageal stenoses. Between February 1997 and July 2002 intraluminal brachytherapy was performed in 19 patients with inoperable esophageal carcinoma (squamous cell carcinoma in 14 cases and adenocarcinoma in 5 cases). All patients had dysphagia at presentation. Brachytherapy was performed using high dose rate afterloading system. Dysphagia was improved in all patients. The mean survival was 248 days. No mechanical complications were observed during introduction of the applicator. Our experience indicates that intraluminal brachytherapy is an effective and safe method of palliation of dysphagia caused by malignant esophageal stenosis.

    • 27 June 2006
      • Vol. 53  (69) , 426-34

    Survival of patients with colorectal cancer liver metastases treated by regional chemotherapy.

    by Bohuslav Melichar, Zbynek Voboril, Jaroslav Cerman, Karolina Melicharová, Jindriska Mergancová, René Voboril, Pavel Jandík

    Liver is the most common site of metastatic disease in colorectal cancer. Superior response rate was demonstrated in trials comparing hepatic arterial administration of cytotoxic agents with systemic chemotherapy. Records of 109 consecutive patients with colorectal carcinoma metastatic to the liver treated by regional chemotherapy, who underwent implantation of a port system into hepatic artery or portal vein tributaries between 1991 and 1999, were reviewed and survival was evaluated using the log-rank test and multivariate analysis (Cox's proportional hazard regression). The median survival from diagnosis was 24 months. Survival was significantly longer for patients treated by radical resection, and patients treated in 1997-1999. On multivariate analysis, treatment by 6 or more chemotherapy cycles, stage 1 liver metastases, treatment with irinotecan and radical resection were associated with better survival, while the presence of extrahepatic disease had an adverse effect on the risk of death. Extrahepatic spread was subsequently detected in almost half of the patients who had originally isolated liver metastases. Patients treated by liver resection had the best outcome, while patients with extrahepatic diseases had poor prognosis. The prognosis of patients treated by regional chemotherapy improved significantly with the advent of irinotecan and better selection.

    • 2 March 2006
      • Vol. 53  (67) , 100-5

    Regional chemotherapy in patients with breast carcinoma liver metastases.

    by Bohuslav Melichar, Zbynek Voboril, Jaroslav Cerman, Karolina Melicharova, Jindriska Mergancova, Rene Voboril, Pavel Jandik

    Although liver is a common site of metastases in breast cancer, isolated liver metastases in patients with disseminated breast cancer are rare. The role of liver-directed therapies in these patients is based on data derived from retrospective analysis of case series. We have reviewed the records of 8 patients with liver metastases and a history of breast cancer treated at our institution over a period of 11 years with regional chemotherapy administered through surgically implanted port systems. Three of the patients also had a history of second primary colorectal carcinoma. One patient had evidence of extrahepatic spread. All patients were treated by regimens based on the combination of 5-fluorouracil and folinic acid. Three patients were also treated by cytoreductive procedures. The median survival times from the diagnosis and port systems implantation were 34 months and 31 months, respectively. Our data support the use of regional intraarterial chemotherapy in patients with metastatic breast cancer limited to the liver.